Skip to content
Compounder
← Stocks

Nice Ltd - Spon Adr

NICEWithin bandExpectations · modest

Held by 2 superinvestors.

Price$101.10
Holders2
Total value$61.0M

SEC 10-K · fundamentals

Business quality

as of 2025-12-31
Revenue growth
+7.7%
Net margin
20.8%
ROE
15.8%
FCF margin
23.7%
Revenue $1.65B → $2.95B · 6y
What makes a business high quality

Valuation · value band

In fair-value range

$95/ sh · growth-anchored intrinsic value
margin of safety
fair value
above fair value
$101
cheaperpricier

Zero-growth floor

$85

Central IV

$95

Optimistic top

$246

Nice Ltd - Spon Adr (NICE): Two methods value the business — a conservative owner-earnings DCF and a growth-credited Greenwald estimate, $85–$246 / sh. Today’s price sits inside both (price $101 as of 2026-08-26).

The middle figure is the main read. The right end is the optimistic case under the same conservative caps — not an absolute ceiling.

Revenue growth 1% (lower of historical trend and fundamental cap, capped by moat) · moat 10 yr · discount 10.6% · Zero-growth downside $85

Price as of 2026-08-26 · yahoo · DGS10 4.7% @ 2026-08-26.

Method & numbers

Model cautions

  • Owner-earnings yield diverges sharply from the 10-year Treasury (over 300 bps).
  • The two methods’ midpoints differ materially — growth assumptions warrant review (over 20%).

A conservative intrinsic-value band (zero-growth floor to growth-capped DCF) plus a tangible asset floor — not investment advice, not a buy/sell signal, and not a price target.

Owner-earnings DCF $79.37 – $111.06 · Greenwald $161.02 – $245.56 (neutral $201.87) · zero-growth base $110.51 · reproduction $29.49

Moat Franchise (moat) · terminal value 39% of present value · owner-earnings yield 9% vs 10Y 4.7%.

Graham earnings-power value (normalized NOPAT)$91.51 – $110.51 / sh

Normalized NOPAT = average operating margin over the years shown × latest-year revenue × (1 − normalized tax); then + D&A − maintenance capex (write A). Unlevered (pre-interest, attributable to all capital). Capitalized at the 9–11% rate band (read as a WACC proxy). Enterprise → equity bridge applied: + cash − total debt.

Years: 2025, 2024, 2023, 2022, 2021

v1 simplifications: Maintenance capex (degraded) deducted in full cash (write A): EPV = (NOPAT + D&A − maintenance capex) / WACC; no tax shield on the capex term. Maintenance-capex methods diverge by 1032% (> 50%); estimate is degraded. Share-based compensation is left as a real expense (not added back).

Buffett owner-earnings value$84.86 – $103.71 / sh

Owner earnings = average net income + average D&A − maintenance capex (zero-growth floor; no ΔNWC). Levered (starts from net income, already after interest — an equity-holder stream). Capitalized at the 9–11% rate band (read as a cost-of-equity proxy). No enterprise→equity bridge: the capitalized result is already equity value (subtracting debt would double-count interest).

Years: 2025, 2024, 2023, 2022, 2021

v1 simplifications: Owner earnings = net income + D&A − maintenance capex (degraded); the working-capital change is excluded (maintenance ΔNWC ≈ 0; growth ΔNWC is carried in growth value, not double-counted). Maintenance-capex methods diverge by 1032% (> 50%); estimate is degraded. One-time items are not separately normalized (multi-year averaging smooths them partially). Share-based compensation is left as a real expense (not added back); see the SBC/OE disclosure. Capitalized at the 9–11% band as a cost-of-equity proxy; no leverage premium applied (net cash or debt within the no-charge range).

Reproduction value = tangible net assets $848.40M + capitalized R&D $1.02B(FY 2025, 2024, 2023, 2022, 2021) = $29.49 / sh. Reproduction value = tangible net assets (equity − goodwill − intangibles) + capitalized R&D (5y straight-line), ÷ diluted shares.

Moat reading: Franchise test compares earnings power (EPV) against reproduction value on both AV_conservative (tangible + capitalized R&D) and AV_reproduction (conservative + acquired-reset proxy). Both must clear the franchise multiple for a moat signal; near it, a commodity; below it, value destruction. A directional reading, not a verdict.

Assumes a narrow moat · competitive-advantage period ≈ 10 years.

Growth value: if the moat holds for 10 yr at ROIIC ≈ 157%, $50.52–$135.05 / sh (neutral $91.36). Conservative, not a forecast.

Window FY 2025, 2024, 2023, 2022, 2021 · discount band 9%11% · normalized tax 21% (Average effective tax rate over 5 year(s), capped at the statutory 21%.) · diluted shares.

Owner-earnings DCF: growth g₁ 1% · OE FY 2025, 2024, 2023, 2022, 2021 · Discount band: 9.16%–12.00% (DGS10 +4.5% to a 12% strict end, as of 2026-08-26). No enterprise→equity bridge: owner earnings already flow to shareholders (post-interest), so no net cash is added and no debt subtracted — matching the engine owner-earnings lamp. Two-method midpoint gap 72%.

What the price is betting

Today's price pencils in about 2.0% a year in owner-earnings for the next few years. Revenue actually grew 12.3% a year.

Below what it has already done.

Roughly, the price needs its historical revenue growth to run about 2 more years to hold up.

How to read intrinsic value

SEC 13F · holders

Superinvestors Holding This Security

2 holders · $61.0M combined · this quarter +0 opened / -0 exited

This quarter2 trimmed
Holders 2 → 2 · last 8q

SEC 13F · notes

Written summary

Nice Ltd - Spon Adr (NICE) is held by 2 of the superinvestors tracked on Compounder, with a combined $61.0M in reported 13F value. The largest position belongs to C.T. Fitzpatrick, where it makes up 1.3% of the portfolio.

Other notable holders by value include Jeremy Grantham (0.0% of its book).

Over the latest quarter, 0 of the tracked filers opened a new position in NICE, 0 added to existing ones, 2 trimmed, and 0 sold out entirely.

Holder counts and values reflect the most recent SEC Form 13F filings, through the quarter ended 2026-06-30. Source: SEC EDGAR. A 13F shows only long US-listed positions and can lag the real portfolio by up to 45 days, so this is disclosed long ownership, not a complete picture.

How to read a 13F

SEC 13F · co-ownership

Also held by these investors

Investors holding Nice Ltd - Spon Adr (NICE) also commonly hold →

NICE's price is not below its conservative value band. See current strike-zone stocks

Also on

Sources· SEC EDGAR 13F as of 2026-06-30 · filed 2026-08-13

Educational data only — not investment advice. 13F positions are self-reported and can lag up to 45 days.

Stay Updated

New-quarter 13F moves and valuation updates, to your inbox.